SCHEMBL6563202

SCHEMBL6563202

CCCCCCCCCCCCCCC(=O)C(=O)OCCC(C)CCC=C(C)C

nearest known ligand 0.58

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.58
FAAH O00519 4/20 0.49
EPHX2 P34913 1/20 0.43
ALDH1A1 P00352 1/20 0.41
CES2 O00748 3/20 0.39
CES1 P23141 3/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 2/20 0.38
DGKA P23743 1/20 0.37
NFE2L2 Q16236 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6562464 0.89 ALOX15 (0.65) ALOX15FAAHEPHX2ALDH1A1USP2
SCHEMBL2171493 0.86 ALOX15 (0.61) ALOX15EPHX2ALDH1A1TSHRDGKA
SCHEMBL19900625 0.86 ALOX15 (0.61) ALOX15EPHX2ALDH1A1TSHRDGKA
SCHEMBL19242397 0.86 ALOX15 (0.61) ALOX15EPHX2ALDH1A1TSHRDGKA
SCHEMBL8664640 0.86 ALOX15 (0.61) ALOX15EPHX2ALDH1A1TSHRDGKA
SCHEMBL560301 0.85 ALOX15 (0.63) ALOX15EPHX2ALDH1A1USP2TSHR
SCHEMBL7699458 0.84 ALOX15 (0.58) ALOX15EPHX2ALDH1A1CES2USP2
SCHEMBL6560758 0.83 ALOX15 (0.69) ALOX15EPHX2ALDH1A1USP2TSHR
SCHEMBL6561520 0.83 ALOX15 (0.57) ALOX15FAAHEPHX2ALDH1A1USP2
SCHEMBL9162630 0.82 ALOX15 (0.56) ALOX15EPHX2ALDH1A1DGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
CN-103958047-B Microcapsules and their use 弗门尼舍有限公司 2017-03-01 CN claimed
US-9334464-B2 Microcapsules and uses thereof FIRMENICH SA (CH) 2016-05-10 US claimed
EP-2822682-A1 MICROCAPSULES AND USES THEREOF Firmenich SA (CH) 2015-01-14 EP claimed
US-20140323376-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2014-10-30 US claimed
CN-103958047-A Microcapsules and their use FIRMENICH & CIE 2014-07-30 CN claimed
WO-2013079435-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2013-06-06 WO claimed
US-12264295-B2 Encapsulated pro-perfume compounds FIRMENICH SA (CH) 2025-04-01 US disclosed
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT FIRMENICH SA (CH) 2023-03-23 US disclosed
US-20230032098-A1 ENCAPSULATED PRO-PERFUME COMPOUNDS FIRMENICH SA (CH) 2023-02-02 US disclosed
CN-115175658-A Perfume system for perfumed consumer products 弗门尼舍有限公司 2022-10-11 CN disclosed
EP-3942009-A1 ENCAPSULATED PRO-PERFUME COMPOUNDS Firmenich SA (CH) 2022-01-26 EP disclosed
CN-113614214-A Encapsulated pro-fragrance compounds 弗门尼舍有限公司 2021-11-05 CN disclosed
US-6369026-B1 FOR USE IN PERFUME OR A COLOGNE, A BATH OR SHOWER GEL, A SHAMPOO, A HAIR SPRAY OR OTHER HAIR-CARE PRODUCT, A COSMETIC PREPARATION, A BODY DEODORANT, A SOLID OR LIQUID AIR-FRESHENER, A DETERGENT OR A FABRIC SOFTENER FIRMENICH SA (CH) 2002-04-09 US disclosed
US-20010014661-A1 Slow release of fragrant compounds in perfumery using alpha-keto esters FIRMENICH SA (CH) 2001-08-16 US disclosed
CN-1302286-A Slow release of fragrant compounds is perfoumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or alpha-keto esters FIRMENICH & CIE (CH) 2001-07-04 CN disclosed
US-6218355-B1 FOR RELEASING FRAGRANT COMPOUND OR COMPOUNDS IN A CONTROLLED MANNER, MAINTAINING A DESIRED SMELL OVER A PROLONGED PERIOD OF TIME FIRMENICH SA (CH) 2001-04-17 US disclosed
EP-1082287-A2 SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS FIRMENICH SA (CH) 2001-03-14 EP disclosed
US-6133228-A Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters FIRMENICH SA (CH) 2000-10-17 US disclosed
WO-1999060990-A2 SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR α-KETO ESTERS FIRMENICH S.A. (CH) 1999-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014661-A1 Slow release of fragrant compounds in perfumery using alpha-keto esters FAAH, KHK, FAAH2 ALOX15 265/4885FAAH 1/4885EPHX2 615/4885
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT PORCN, FAAH2, FASN ALOX15 115/4885FAAH 38/4885EPHX2 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.